ATA6952004A - Resveratrol enthaltende arzneistoffgemische sowie deren verwendung zur herstellung von arzneimitteln - Google Patents

Resveratrol enthaltende arzneistoffgemische sowie deren verwendung zur herstellung von arzneimitteln

Info

Publication number
ATA6952004A
ATA6952004A AT0069504A AT6952004A ATA6952004A AT A6952004 A ATA6952004 A AT A6952004A AT 0069504 A AT0069504 A AT 0069504A AT 6952004 A AT6952004 A AT 6952004A AT A6952004 A ATA6952004 A AT A6952004A
Authority
AT
Austria
Prior art keywords
medicaments
resinatrolyte
preparation
resinatrolyte medicaments
Prior art date
Application number
AT0069504A
Other languages
English (en)
Other versions
AT413262B (de
Inventor
Thomas Dr Szekeres
Walter Mag Dr Jaeger
Original Assignee
Thomas Dr Szekeres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Dr Szekeres filed Critical Thomas Dr Szekeres
Priority to AT0069504A priority Critical patent/AT413262B/de
Priority to PCT/AT2005/000122 priority patent/WO2005102298A1/de
Publication of ATA6952004A publication Critical patent/ATA6952004A/de
Application granted granted Critical
Publication of AT413262B publication Critical patent/AT413262B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0069504A 2004-04-22 2004-04-22 Resveratrol enthaltende arzneistoffgemische sowie deren verwendung zur herstellung von arzneimitteln AT413262B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT0069504A AT413262B (de) 2004-04-22 2004-04-22 Resveratrol enthaltende arzneistoffgemische sowie deren verwendung zur herstellung von arzneimitteln
PCT/AT2005/000122 WO2005102298A1 (de) 2004-04-22 2005-04-07 Resveratrol oder resveratrol-derivate enthaltende arzneistoffgemische sowie deren verwendung zur herstellung von arzneimitteln

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0069504A AT413262B (de) 2004-04-22 2004-04-22 Resveratrol enthaltende arzneistoffgemische sowie deren verwendung zur herstellung von arzneimitteln

Publications (2)

Publication Number Publication Date
ATA6952004A true ATA6952004A (de) 2005-06-15
AT413262B AT413262B (de) 2006-01-15

Family

ID=34637621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0069504A AT413262B (de) 2004-04-22 2004-04-22 Resveratrol enthaltende arzneistoffgemische sowie deren verwendung zur herstellung von arzneimitteln

Country Status (2)

Country Link
AT (1) AT413262B (de)
WO (1) WO2005102298A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005207029B2 (en) 2004-01-20 2011-09-01 Brigham Young University Novel sirtuin activating compounds and methods for making the same
EP2637652A2 (de) 2010-11-10 2013-09-18 Katholieke Universiteit Leuven Osteoklastenaktivität
CN102050703B (zh) * 2010-12-15 2013-03-27 厦门大学 一种白藜芦醇衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1207907B1 (de) * 1999-08-13 2004-11-03 University Of Maryland Biotechnology Institute Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür
CA2408152A1 (en) * 2000-05-05 2001-11-15 Wisconsin Alumni Research Foundation Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
US20070191627A1 (en) * 2003-08-14 2007-08-16 Thomas Szekeres Stilbene derivatives and their use in medicaments

Also Published As

Publication number Publication date
WO2005102298A1 (de) 2005-11-03
AT413262B (de) 2006-01-15

Similar Documents

Publication Publication Date Title
ATE395342T1 (de) 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
DE602005027546D1 (de) Aryl- und heteroarylpiperidincarboxylatderivate, deren herstellung und deren verwendung in form von faah-enzyminhibitoren
DE602005002470D1 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
ATE397629T1 (de) Polyethylen und katalysatorzusammensetzung für dessen herstellung
DE50212302D1 (de) 17alpha-alkyl-17beta-oxy-estratriene und zwischenprodukte zu deren herstellung, verwendung der 17alpha-alkyl-17beta-oxy-estratriene zur herstellung von arzneimitteln sowie pharmazeutische präparate
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
ATE461285T1 (de) Herstellung von tnfr-fc
DE60318188D1 (de) Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
DE60233825D1 (de) BENZOATESÄURE-2-(a-HYDROXYPENTYL)ESTER UND DESSEN HERSTELLUNG UND VERWENDUNG
DE112007003309A5 (de) Knochenimplantat sowie Set zur Herstellung von Knochenimplantaten
DE102009035301A8 (de) Verfahren zur Herstellung von Dibenz[c,e][1,2]-oxaphosphorin-Derivaten, Amino-dibenz[c,e][1,2]-oxaphosphorin sowie deren Verwendung
ATE512970T1 (de) Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung
DE602005015027D1 (de) Glucocorticoid-mimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und deren verwendung
ATE502035T1 (de) 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
DE502004000891D1 (de) Organosilylfunktionalisierte partikel und deren herstellung
ATE513537T1 (de) Etui zur aufnahme einer arzneimittelpackung sowie deren verwendung
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
AT502301A3 (de) Röntgenanode und verfahren zur herstellung derselben
DE602004030564D1 (de) 2-substituierte phenyl-5,7-dialkyl-3,7-dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung
ATE459608T1 (de) Oxopiperidinderivate, ihre herstellung und therapeutische verwendung
DE602005023127D1 (de) Künstliche physiologische salzlösung und verfahren zu ihrer herstellung
ATE542806T1 (de) Diarylmethylpiperazinderivate, deren herstellung und deren verwendung
DE502007007012D1 (de) Polyetheramin-makromonomere mit zwei benachbarten hydroxylgruppen und ihre verwendung zur herstellung von polyurethanen
ATE417846T1 (de) Aminotropanderivate, deren herstellung und deren therapeutische verwendung
DE502005004711D1 (de) Fluorsilankondensationsprodukte, deren Herstellung und Verwendung zur Oberflächenmodifizierung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
MM01 Lapse because of not paying annual fees

Effective date: 20110615